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Patients with Parkinson’s disease (PD) may develop progressive dementia late in their 
clinical course. Dementia in PD is mostly related to neuropathological findings of 
extensive Lewy bodies (LBs), with or without the coexistence of Alzheimer’s disease 
(AD) pathology. Aphasia has been reported in patients with LB diseases with AD 
pathology; however, there have been no reports of typical PD patients developing 
progressive aphasia during their clinical course. We describe a female PD patient who 
later developed progressive conduction aphasia characterized by phonemic paraphasia 
and disturbance in repetition of short sentences without disturbance in writing or auditory 
comprehension. No episodes of fluctuations of attention, memory complaints, or 
planning errors were observed. She experienced episodes of visual hallucination. Her low 
scores on the Mini-Mental State Examination suggested impairment of orientation and 
attention, and her scores on Raven’s Coloured Progressive Matrices test indicated 
impaired visuospatial functions. However, her cognitive deficits were not sufficiently 
severe to impair her daily life. Brain magnetic resonance images revealed atrophy of the 
left superior temporal gyrus and widening of the left Sylvian fissure. 
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[18F]-fluorodeoxyglucose positron emission tomography revealed glucose 
hypometabolism in the left cerebral hemisphere. These findings may be related to 
conduction aphasia. During the progression of PD lesions, the brainstem LB is assumed 
to take an upward course, extend to the limbic system, and then extend to the neocortex. 
Conduction aphasia observed in our patient may be associated with an unusual 
progression of the LB pathology from the brainstem to the left temporoparietal lobe. 
(247 words) 
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Introduction 
Patients with Parkinson’s disease (PD) may develop progressive dementia late in their 
clinical course [1-3]. Dementia in PD is mostly related to neuropathological findings of 
extensive Lewy bodies (LBs), with or without the coexistence of Alzheimer’s disease 
(AD) pathology involving various subcorticocortical neural systems [1, 4]. PD with 
dementia (PDD) shares neuropathological features with dementia with LB (DLB). The 
general term LB diseases (LBD) represents the disease spectrum that includes PDD and 
DLB [4]. In addition, a rare case of PD accompanied by Pick’s disease has been described 
[5]. Aphasia has been reported in patients with LBD with AD pathology [6]; however, 
there have been no reports of typical PD patients developing progressive aphasia during 
their clinical course. In this paper, we describe a female PD patient without apparent 
dementia who showed progressive conduction aphasia characterized by phonemic 
paraphasia and disturbance in repeating short sentences. These symptoms suggested an 




A 75-year-old right-handed Japanese woman complaining of progressive aphasia was 
admitted to our hospital. She had no family history of dementia or other neurological 
disorders. Her history was not contributory. She had been experiencing gait disturbance, 
bradykinesia, and mild bilateral hand rigidity since the age of 67. No other symptoms or 
signs, including rest tremor, supranuclear gaze palsy, cerebellar signs, autonomic signs, 
or dementia with disturbance of memory, language, or praxis, were observed. All her 
initial symptoms had responded well to levodopa therapy. At the age of 68, mild diffuse 
brain atrophy with lateral ventriclular dilatation was observed on brain magnetic 
resonance images (MRI) (Fig. 1a) and her myocardial accumulation of 
123I-metaiodobenzylguanidine (123I-MIBG) decreased, leading to diagnosis of PD 
without dementia. Although she had received treatment with a combination of levodopa, 
pramipexole, and amantadine, her gait disturbance and bradykinesia progressed gradually 
and postural instability appeared. At the age of 74, she experienced three times episodes 
of transient visual hallucinations showing formed visions of a man that was vivid in 
coloration. Around this age, progressive speech disturbance characterized by phonemic 
paraphasia appeared. However, her social behavior was appropriate according to an 
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interview of her caregiver. No episodes of fluctuations of attention, memory complaints, 
or planning errors were observed at the time of admission to our hospital. In addition, 
episodes of rapid eye movement sleep behavior disorders, apathy, changes in personality 
and mood, delusions or excessive daytime sleepiness have not yet been observed. At the 
age of 75, an examination showed rigidity in her neck and left upper extremity. Her 
motion was bradykinetic. She had bilateral hyperreflexia with positive plantar reflexes 
that may have resulted from cervical spondylotic myelopathy. She showed postural 
instability but orthostatic hypotension was not observed. Although no anarthria was 
observed in her spontaneous speech, phonemic paraphasia and disturbances in repetition 
of short sentences were apparent. She recognized her errors and tried to rectify them. Her 
writing and auditory comprehension were normal. She had no signs of the following 
apraxias or agnosias on the bedside testing: limb kinetic apraxia, ideomotor apraxia, 
ideational apraxia, dressing apraxia, constructional apraxia, visual agnosia, 
hemiasomatognosia, right–left disorientation, or hemispatial agnosia. Her Mini-Mental 
State Examination (MMSE) score was 24 out of 30 because of the subject missing 2 
points on place orientation, 3 points on serial 7’s and 1 point on sentence repetition. The 
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Raven’s Coloured Progressive Matrices test (RCPM) score was 9 out of 36, while the 
mean RCPM score (SD) in the Japanese normal population aged between 70 and 79 years 
old is 27.9 (5.396). The Clock Drawing Test was appropriate. Blood chemistry analysis 
showed nothing unusual. Brain MRI disclosed diffuse cortical atrophy, which was 
marked in the left superior temporal gyrus, and widening of the left Sylvian fissure (Fig. 
1b). [18F]-fluorodeoxyglucose positron emission tomography (PET) revealed glucose 
hypometabolism in the left cerebral hemisphere, which was more apparent in the frontal 
and temporal lobes, and the bilateral parietal and occipital lobes (Fig. 1c). 
Three-dimensional stereotactic surface projection (3D-SSP) [7] disclosed these findings 
(Fig. 1d, e). No significant findings were observed by 11C-labeled Pittsburgh 
Compound-B (PIB) PET study.   
 
Discussion 
In this paper, we describe a PD patient who later developed progressive aphasia without 
apparent dementia. Her initial clinical features and good response to levodopa therapy 
satisfied the Queen Square Brain Bank clinical diagnostic criteria for PD [8]. In addition, 
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according to the decreased myocardial accumulation of 123I-MIBG [1, 9], we diagnosed 
her with PD before the appearance of speech disturbance. Although she experienced 
episodes of visual hallucinations and language disturbances and showed a low score on 
MMSE suggesting impairment of orientation and attention as well as on a RCPM test 
indicating impaired visuospatial functions, her features did not meet the criteria for PDD 
diagnosis because her cognitive deficits were not sufficiently severe to impair her daily 
life [1-3]. 
Her speech disturbance was characterized by phonemic paraphasia, 
disturbances in repeating short sentences, and no anarthria in her spontaneous speech, 
which has been classified as conduction aphasia [10, 11]. Generally, conduction aphasia 
is found to be caused by infarcts in the left temporoparietal lobe, especially in the superior 
temporal gyrus, supramarginal gyrus, and inferior parietal lobe [10]. Patients with 
neurodegenerative diseases rarely show conduction aphasia, and this has been previously 
reported in only one patient who had pathologically proven corticobasal degeneration 
(CBD) with severe atrophy and tau-positive lesions in the left superior temporal gyrus 
[11]. Our patient showed atrophy of the left superior temporal gyrus, dilatation of the left 
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Sylvian fissure (Fig. 1b), and obvious glucose hypometabolism in the left frontal and 
temporal lobes on 3D-SSP (Figs. 1d, e). These findings may be related to conduction 
aphasia. 
 There have been no reports of PD patients with progressive conduction aphasia. 
Preserved core language functions are characteristic for PDD patients [1, 3]. Our patient 
had no infarcts or PIB-positive amyloid accumulation, indicating no evidence of 
additional AD pathology in the brain. A significant proportion of elderly people with 
dementia have combined degenerative disorders [12], and thus, the possibility of 
coexistence of other neurodegenerative conditions, including CBD [11], could not be 
excluded. However, the episodes of transient visual hallucinations in our patient 
suggested the presence of cortical LB pathology [1, 13]. A voxel-based morphometric 
study concluded in LBD with dementia patients showed cerebral cortical atrophy in the 
occipital, frontal, and parietal lobes [1, 14].  During the progression of PD lesions, the 
brainstem LB pathology may take an upward course, extend to the limbic system, and 
then extend to the neocortex [15]. The superior temporal gyrus, which observed atrophy 
in our patient, is usually involved in the late stage [15]. The unique cortical manifestation 
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and conduction aphasia observed in our PD patient may be associated with an unusual 
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Figure 1: T1-weighted magnetic resonance images of coronal sections of the patient at the 
age of 68 (a) and 75 (b) show the progression of dilatation of the left Sylvian fissure 
(white arrows) and atrophy of the left superior temporal gyrus (black arrowheads). 
[18F]-fluorodeoxyglucose positron emission tomography (c) and three-dimensional 
stereotactic surface projection (3D-SSP) images (d, e) show glucose hypometabolism in 
the left frontal (arrow) and temporal (arrowheads) lobes compared with the right cerebral 
hemisphere. In addition, glucose hypometabolism was observed in the bilateral parietal 
and occipital lobes. Right-lateral (d) and left-lateral (e) views of 3D-SSP.  

